BCRX Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into BCRX

Also see:
• BCRX stock yearly return 2016
• BCRX stock yearly return 2017
• BCRX stock yearly return 2018
• BCRX stock yearly return 2019
• BCRX stock yearly return 2020
• BCRX stock yearly return 2021
• BCRX stock yearly return 2022
• BCRX stock yearly return 2023
• BCRX stock yearly return 2024
• BCRX stock yearly return 2025
• BCRX YTD return

Compare BCRX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	04/19/2016
End date:	04/17/2026
Start price/share:	$3.07
End price/share:	$9.50
Dividends collected/share:	$0.00
Total return:	209.45%
BCRX Average Annual Return:	11.96%
Starting investment:	$10,000.00
Ending investment:	$30,947.74
Years:	10.00

BCRX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. Co. leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the U.S.. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. The BCRX average annual return 10 years is shown above.

The Average Annual Return on the BCRX average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether BCRX average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the BCRX average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free BCRX Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

BioCryst Pharmaceuticals (BCRX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

BDSX Average Annual Return
BDTX Average Annual Return
BDX Average Annual Return
BEAM Average Annual Return
BEAT Average Annual Return
BFLY Average Annual Return
BFRG Average Annual Return
BFRI Average Annual Return
BGLC Average Annual Return
BGMS Average Annual Return
More Healthcare companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, BioCryst Pharmaceuticals (BCRX) ranks within the highest 50% of all stocks whose returns we have reviewed.

What has the average annual return been for BCRX over the past ten years?

✔️Accepted answer: The ten year BCRX average annual return has been 11.96%.

What start date was used in your BCRX average annual return calculation?

✔️Accepted answer: The start date was 04/19/2016.

What end date was used in your BCRX average annual return calculation?

✔️Accepted answer: The end date was 04/17/2026.

If I had invested $10,000 into BCRX ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 04/17/2026, you would have $30,947.74.

What does that work out to on a total return basis?

✔️Accepted answer: The BCRX ten year total return ending 04/17/2026 works out to 209.45%.

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.

BCRX Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved